Fidelity China Special Situations - Neutral

INVESTMENT TRUST RESEARCH UPDATE: Morningstar analysts move the Rating to Neutral from Under Review

Szymon Idzikowski 29 August, 2014 | 8:20PM
Facebook Twitter LinkedIn

We have awarded the Fidelity China Special Situations Investment Trust (FCSS) a Morningstar Analyst Rating™ of Neutral. Previously the fund’s rating was Under Review following the departure of former fund manager Anthony Bolton. We think the transition from Bolton to Dale Nicholls has been smooth. Nicholls is an experienced investor who has built an impressive track record at Fidelity Pacific; however, Fidelity Pacific is a regional fund rather than a country-specific fund, and Nicholls has yet to prove his process is replicable here. This is his first time in charge of a closed-end fund and we are also cognisant of an increased turnover in the Chinese team. Thus, we believe a Neutral rating is appropriate at present.

Find out more about how Morningstar analysts rate funds and investment trusts here.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
Fidelity China Special Ord200.89 GBX-0.05Rating

About Author

Szymon Idzikowski

Szymon Idzikowski  is a closed-end fund analyst with Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures